Dabur profit jumps 34% to ₹377.3 cr in March quarter
NEW DELHI: Home-grown FMCG major Dabur India Ltd on Friday reported an increase of 33.98% in consolidated net profit at ₹377.29 crore for the fourth quarter ended March 2021.
The company had posted a net profit of ₹281.60 crore in the January-march quarter a year ago, Dabur India said in a BSE filing.
Its revenue from operations during January-march 2021 jumped 25.27% to ₹2,336.79 crore, compared with ₹1,865.36 crore in the year-ago period.
Dabur India CEO Mohit Malhotra said in a challenging market environment, Dabur has delivered another consecutive quarter of double-digits and sales growth.
“Dabur’s financial situation remains strong with a 25.6% growth in our operating profit during the fourth quarter of 2020-21.
“Our India FMCG business led the growth with a 28.3% surge, with an underlying best-ever FMCG volume growth of 25.4% during the fourth quarter of 2020-21,” said Malhotra.
Dabur’s revenue from the consumer care business segment was up 26.36% to ₹2,009.63 crore as against ₹1,590.38 crore in the year-ago period.
Revenue from food business was up 24.93% to ₹274.14 crore as compared with ₹219.44 crore in the year-ago period.
However, its retail business was down 18.2% to ₹23.13 crore from ₹28.27 crore in the corresponding period of the previous year.
Revenue from other segments was up 17% to ₹23.95 crore, against ₹20.47 crore a year ago.
Dabur’s international business reported a growth of 19.4% in rupee terms and 21% in constant currency terms.
Dabur India’s total expenses was at ₹1,969.54 crore, up 24.62% as against ₹1,580.49 crore a year ago.
For the full fiscal year 2020-21, Dabur’s net profit was up 17.06% to ₹1,694.95 crore. It was ₹1,447.92 crore in the previous year.
Its revenue from operation in the financial year was ₹9,561.65 crore, up 9.86%. It was ₹8,703.59 crore in 2019-20.
“Dabur continued to gain market share across all key categories like shampoos, toothpaste, hair oils, chyawanprash and packaged juices and nectars, during the quarter and the full year,” the company said in a post-earning statement.
Over the current status, Dabur said the operating environment remains challenging with the emergence of the second and more devastating wave of Covid-19.
“Despite the uncertainty related to the extent and length of the fresh wave, we will respond to the challenges by sharpening focus on our power brands and the ayurvedic healthcare portfolio,” Malhotra added.
He added the company will also build increased flexibility into its planning and go-to-market strategies to drive profitable growth and gain market share.
Meanwhile, Dabur informed its board in a meeting held on Friday that it has recommended a final dividend of 300%, which is ₹3 per equity share having a face value of ₹1 each for the financial year 2019-20.